UK Renal Pharmacy Group to Showcase Renal Pharmacy Expertise at Clinical Pharmacy Congress 2025 – Stand J13 The UK Renal Pharmacy Group is thrilled to announce its participation in the Clinical Pharmacy Congress (CPC) 2025, the UK’s leading event for pharmacy professionals. Taking place on 9-10 May...

We are pleased to announce the launch of a new patient information leaflet, Hepatitis B Vaccination for People with Chronic Kidney Disease, produced in collaboration with the UK Health Security Agency (UKHSA) and NHS England. This comprehensive guide provides essential information about hepatitis B...

At the RPG Conference 2024, a poster presented by East and North Hertfordshire NHS Trust highlighted the results of an audit examining the RAG (Red, Amber, Green) ratings assigned to SGLT2 inhibitors—dapagliflozin and empagliflozin—and finerenone by ICBs in England. These medications, endorsed by...

The UK Renal Pharmacy Group has produced a statement regarding safety considerations for the use of Metolazone preparations in adults. Please follow the link below to access the document.If you have any questions, please email rpg@renal.org

We’re pleased to have recently welcomed the UK Renal Pharmacy Group (RPG) into the Renal Association after their full integration on 1st of January 2021.The RPG was set up in 1982 to facilitate high-quality education, training and research for pharmacists involved in provisions of pharmaceutical...